Interpace Diagnostics eyeing cash raise via common stock offering
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Interpace Diagnostics Group Inc. is looking to raise money via an underwritten offering of shares.
The diagnostic services provider said the offering will help its working capital, debt repayment and general corporate requirements.
Pricing will occur at a later date.
Maxim Group LLC will act as the sole book-running manager of the issue.
